Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome

BACKGROUND: The gut microbiota influences many aspects of host physiology, including immune regulation, and is predictive of outcomes in cancer patients. However, whether conventional myelosuppressive chemotherapy affects the gut microbiota in humans with non-haematological malignancy, independent o...

Descripción completa

Detalles Bibliográficos
Autores principales: Papanicolas, Lito E., Sims, Sarah K., Taylor, Steven L., Miller, Sophie J., Karapetis, Christos S., Wesselingh, Steve L., Gordon, David L., Rogers, Geraint B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141218/
https://www.ncbi.nlm.nih.gov/pubmed/34022842
http://dx.doi.org/10.1186/s12885-021-08296-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141218/
https://www.ncbi.nlm.nih.gov/pubmed/34022842
http://dx.doi.org/10.1186/s12885-021-08296-4

Ejemplares similares